Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 6, Issue 246, Pages 246ra99-246ra99
Publisher
American Association for the Advancement of Science (AAAS)
Online
2014-07-24
DOI
10.1126/scitranslmed.3009131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
- (2012) YuXiang Fang et al. HEPATOLOGY
- MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN
- (2011) Guangyun Tan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation
- (2011) GV Baracho et al. CURRENT OPINION IN IMMUNOLOGY
- Monophosphorylation of CD79a and CD79b ITAM Motifs Initiates a SHIP-1 Phosphatase-Mediated Inhibitory Signaling Cascade Required for B Cell Anergy
- (2011) Shannon K. O'Neill et al. IMMUNITY
- Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells
- (2011) Jian Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis
- (2011) X. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF
- (2010) Y.-T. Chou et al. CANCER RESEARCH
- B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans
- (2010) Danielle T. Avery et al. JOURNAL OF EXPERIMENTAL MEDICINE
- miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics
- (2010) Nadav Bar et al. PLoS One
- The PI3K Isoforms p110 and p110 Are Essential for Pre-B Cell Receptor Signaling and B Cell Development
- (2010) F. Ramadani et al. Science Signaling
- Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas
- (2009) K. A. Sarosiek et al. BLOOD
- PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
- (2009) Lakshmi Srinivasan et al. CELL
- Distinct response in maintenance of human naive and memory B cells via IL-21 receptor and TCL1/Akt pathways
- (2009) Haruo Nagumo et al. CELLULAR IMMUNOLOGY
- Genetic dissection of the miR-17 92 cluster of microRNAs in Myc-induced B-cell lymphomas
- (2009) P. Mu et al. GENES & DEVELOPMENT
- Suppression of Phosphatidylinositol 3,4,5-Trisphosphate Production Is a Key Determinant of B Cell Anergy
- (2009) Cecille D. Browne et al. IMMUNITY
- Elevated Production of B Cell Chemokine CXCL13 is Correlated with Systemic Lupus Erythematosus Disease Activity
- (2009) C. K. Wong et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Identification and Characterization of a Human CD5+ Pre-Naive B Cell Population
- (2009) J. Lee et al. JOURNAL OF IMMUNOLOGY
- Tenets of PTEN Tumor Suppression
- (2008) Leonardo Salmena et al. CELL
- BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten
- (2008) Shuhua Cheng et al. CELL RESEARCH
- Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
- (2007) Rosanne Spolski et al. Annual Review of Immunology
- Targeting phosphoinositide 3-kinase—Moving towards therapy
- (2007) Romina Marone et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started